Daily non-political popular news in brief.

Longer treatment benefits sleep apnea patients

06-06-2007 · EurekAlert!

Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.

Keywords: longer, treatment, benefits, sleep, apnea, patients, benefit, patient

« Previous | Next »

Similar news on "Longer treatment benefits sleep apnea patients":

News briefs from the December issue of Chest
12-10-2007 · EurekAlert!
In three separate studies researchers have found the following: A new study suggests that patients who suffer from obstructive sleep apnea and hypertension could benefit from good continuous positive airway pressure treatment compliance; New research from the Netherlands suggests that oral prednisolone is just as effective in treating COPD exacerbations as its intravenous counterpart; A Japanese study looks at prevalence and predictors of excessive carbon dioxide in the blood during the day.
Similar news · Read more »
Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
Rapid-acting insulin analogues in diabetes mellitus type 1 -- Superiority not proven
07-17-2007 · EurekAlert!
There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1. The evidential value and design of studies available so far are inadequate and do not allow conclusions regarding most patient-relevant therapy goals, such as the reduction in long-term complications or overall mortality. Due to the lack of data, the benefit of rapid-acting insulin analogues in children and adolescents is unclear.
Similar news · Read more »
Educating OSA patients about CPAP critical to successful treatment
06-13-2007 · EurekAlert!
One of the most important ways to help patients manage their obstructive sleep apnea (OSA) is to effectively educate them about CPAP, the most common and effective treatment for OSA.
Similar news · Read more »
Nasal cannula may be viable treatment for sufferers of sleep apnea
07-16-2007 · EurekAlert!
Researchers at Johns Hopkins University have found that symptoms in patients with obstructive sleep apnea and hypopnea can be significantly reduced through treatment with nasal insufflation, using a nasal cannula to deliver warm, humidified air at a high flow rate.
Similar news · Read more »
From clinical cancer research: rethinking therapeutic cancer vaccine trials
07-03-2007 · EurekAlert!
Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
Similar news · Read more »
Older patients reap positive benefits with high dose statins
07-02-2007 · EurekAlert!
Can older patients with stable cardiovascular disease benefit from the same cholesterol lowering drugs used by younger patients? The answer is yes, according to a study report in the July 3, 2007 issue of the Annals of Internal Medicine. The key to beneficial treatment appears to be dosage, says lead author Nanette K. Wenger, M.D., professor of medicine in the Division of Cardiology, Emory University School of Medicine, and chief of cardiology at Grady Memorial Hospital.
Similar news · Read more »
Deep brain stimulation offers new hope for dystonia treatment
11-21-2006 · EurekAlert!
Dystonia, a group of diseases that cause a patient's muscles to involuntary contract with movement, has had a relatively limited and ineffective number of treatments in the past. New research shows that a recently developed surgical treatment, deep brain stimulation (an off switch for the brain), has provided dramatic benefits in some patients.
Similar news · Read more »
Research shows survival benefit for leukemia patients treated with arsenic trioxide
06-04-2007 · EurekAlert!
Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
Similar news · Read more »
Risk factors for developing complications from sleep apnea surgery
10-16-2006 · EurekAlert!
Patients undergoing surgery to correct sleep apnea are more likely to have complications if their condition is severe, they have a high body mass index, they have other medical problems or they are undergoing certain other surgical procedures at the same time, according to a report in the October issue of Archives of Otolaryngology -- Head & Neck Surgery, one of the JAMA/Archives journals.
Similar news · Read more »